MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease

    S. Holden, L. Medina, B. Hoyt, S. Sillau, J. Goldman, D. Weintraub, B. Kluger (Aurora, CO, USA)

  • Validation of actigraphy-derived sleep metrics in Parkinson’s disease (PD) patients and elderly controls, taking into account clinical and physiological status

    J. Munro, R. Wolz, D. Hill, Y. DAUVILLIERS (London, United Kingdom)

  • Validation of Computerised Measures of Executive Functioning for use in Parkinson’s Disease Assessments.

    T. Dominey, C. Carroll, R. Noad, C. Newman, S. Hall (Plymouth, United Kingdom)

  • Validation of the MDS Research Criteria for Prodromal Parkinson’s Disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort

    S.-M. Fereshtehnejad, J. Montplaisir, A. Pelletier, J.-F. Gagnon, D. Berg, R. Postuma (Montreal, QC, Canada)

  • Validation of the performance based Erlangen Test of Activities of Daily Living in PD

    I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg (Tübingen, Germany)

  • Validation of the Utility of Brief Smell Identification Test Simplified Chinese Version 2 in Chinese Parkinson’s disease

    M. Cao (Beijing, China)

  • Variability of spiral tremor during daily life of subjects with Essential Tremor

    J. Thompson-Westra, T. Wu, H. Cao, A. Pigg, G. Leodori, F.A. Vial Undurraga, M. Hallett, D. Haubenberger (Bethesda, MD, USA)

  • Variation in Longevity Gene KLOTHO Associates with Measures of Resilience Against Parkinson’s Disease

    N. Luthra, J. Ostrem, D. Dubal (San Francisco, CA, USA)

  • Variations in ANO3 gene in patients with cervical dystonia

    V. Han, V. Habalova, L. Klimcakova, J. Zidzik, M. Skorvanek, Z. Gdovinova (Kosice, Slovakia)

  • Vascular hemiballismus due to a lentiform nucleus infarct

    D. Gams Massi, J. Nyassinde, K. Toure, N.S. Diagne, M. Ndiaye, A.G. Diop, M.M. Ndiaye (Dakar, Senegal)

  • Vascular Parkinsonism, an underdiagnosed Parkinsonian variant : An outpatient study from a South Indian Superspeciality Private Hospital

    S. Jaiswal, M. Reddy (Hyderabad, India)

  • Verticality Perception Differentially Correlates with Pisa Syndrome in Parkinson’s Disease

    Y.E. Huh, W.-H. Chung, K. Kim, J.W. Cho (Seongnam-si, Republic of Korea)

  • Video-oculography assessment in neurodegenerative ataxias and Neimann Pick Type C

    H. Hanagasi, Z. Karaarslan, B. Bilgiç, Z. Tüfekçioğlu, A. Demirtaş Tatlıdede, H. Gürvit, M. Emre (İstanbul, Turkey)

  • Videoendoscopy study of swallowing in Parkinson’s disease

    J. Fukae, Y. Tsuboi, S. Fujioka, G. Umemoto (Fukuoka, Japan)

  • Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy

    W. Meissner, F. Bassil, P. Guerin, N. Dutheil, Q. Li, M. Klugmann, E. Bezard, P.-O. Fernagut (Bordeaux, France)

  • Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Interim Analysis

    C. Tarolli, K. Andrzejewski, M. Bull, S. Goldenthal, M. O'Brien, T. Simuni, G. Zimmerman, K. Biglan, E.R. Dorsey (Rochester, NY, USA)

  • VIT-D and Tics Movement Disorder

    N. GEMAWAT (MUMBAI, India)

  • Vitamin D and Clinical Phenotypes of Parkinson’s Disease

    F. Jamal, G. Jackson, S. Moore, A. Sarwar (Houston, TX, USA)

  • Vitamin D in the Parkinson’s Associated Risk (PARS) Study

    M. Fullard, S. Xie, K. Marek, M. Stern, D. Jennings, A. Siderowf, A. Chen-Plotkin (Philadelphia, PA, USA)

  • Vmat2 heterozygote mice display motor dysfunction and progressive depressive-like behaviors

    K. Ma, J. Huang, L. Liu, C. Han, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

  • Voice Cepstral Analysis in Adductor-Type Spasmodic Dysphonia

    L. Marsili, A. Suppa, G. Costantini, G. Saggio, D. Casali, G. Delgado, G. Ruoppolo, A. Berardelli (Rome, Italy)

  • Voice Therapy Normalizes Feedforward and Feedback Networks of the Speech Motor System

    S. Narayana, C. Franklin, E. Peterson, D. Robin, P. Fox, L. Ramig (Memphis, TN, USA)

  • Volume analysis and localization of midbrain hyperechogenecities via TCS and MRI

    A. Plate, S.-A. Ahmadi, K. Boetzel (Munich, Germany)

  • Volumetric analysis of limbic structures in patients with functional movement disorders

    C. Maurer, K. LaFaver, G. Limachia, G. Capitan, S. Horovitz, M. Hallett (Bethesda, MD, USA)

  • Voxel-based Analysis of Cholinesterase Inhibitor Response in Lewy Body Disorders: A Prospective Observational Study

    J. Compagnone, H. Mustaerts, J. Li, M. Freedman, K. Galit, J. Lee, J. Kennedy, R. Chen, D. Tang-Wai, A. Lang, N. Herrmann, S. Black, M. Masellis (Toronto, ON, Canada)

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley